Europe Cannabis Market 2022-2027

    Multi User License - $2,500

    In Stock

    Coming Soon




    Cannabis would be a tall shrub with such a strong erect stem and is used as a narcotic and is now being approved for medicinal purposes. The research examines the major elements of the legal cannabis industry.


    Because cannabis is widely utilised for therapeutic purposes in the region, the cannabis business has expanded and matured tremendously in the United States. Marijuana, as a pharmaceutical drug, continues to be popular in Europe both between medicinal and recreational purposes users.


    Cannabis is supplied to patients living with chronic conditions such as Parkinson’s, Alzheimer’s, cancer, and a variety of neurological ailments. CBD oil is becoming more popular due to its fitness and wellness benefits.


    Cannabidiol oil is used to treat sadness and anxiety, as well as to protect against diabetes, relieve cancer symptoms, and reduce inflammation. The European marijuana industry is predicted to increase considerably over the coming quarters, owing to the increasing use of cannabidiol (CBD)-based medications to cure diseases.


    infographic: Europe Cannabis Market, Europe Cannabis Market Size, Europe Cannabis Market Trends, Europe Cannabis Market Forecast, Europe Cannabis Market Risks, Europe Cannabis Market Report, Europe Cannabis Market Share


    Strong regulations requirements governing marijuana marketing and manufacturing in many countries can be difficult for manufacturers and investors to follow. The species also was recognized as hemp; however this name is commonly used in reference primarily to Cannabis types grown for non-drug purposes.


    Cannabis has historically been used by the natural fibers, hemp oil as well as lipids, cannabis stalks for vegetable as well as beverage uses, therapeutic applications, and also as a pleasure narcotic. Derived from hemp goods are created from marijuana plants that have been chosen for their high fiber content.



    Despite Europe is an enticing market for multinational corporations and investors concerned in recreational marijuana, whose regulatory framework is very scattered. Cannabis legalisation is a relatively recent invention in Europe, despite the fact that every European country has a lengthy history of legalisation support.


    But even though the medicinal cannabis industry has grown well entrenched in certain European nations, legislation developers are still struggling to find the best approach to meet consumption.


    The availability of healthcare marijuana in Europe aided in the dissemination of cannabis information throughout the continent, showcasing the plant’s therapeutic virtues. Nonetheless, the stigmatized associated with cannabis remains prevalent in European society.


    Additionally, in certain European nations, cannabis legalisation is highly controversial among political parties. As a result, legalising cannabis with such an environment may be perilous, as knowledge and marijuana acceptability attempt to provide the groundwork for an evidence-based public conversation on legalizing marijuana.


    The instance of legalisation in Malta can help other European countries understand the path that they may pursue. Releaf Malta, a neighbourhood non-profit Organisation, campaigned tirelessly for decades to legalise cannabis upon that country.


    From December 2021, this same administration of Malta legalised the cultivation of four to 6 plants in residence, the possession of seven grammes, the establishment of a specialised government body, and the formation of social cannabis clubs. Although sales are still prohibited, this achievement represents a crucial milestone for the cannabis industry in Europe.



    The Europe Cannabis Market can be segmented into following categories for further analysis.

    By Application

    • Commercial Application
    • Industrial Application
    • High-Capacity User Application
    • Residential Application


    By Usage Classification Type

    • Pain Management
    • Medical Management
    • Neurological Health Management
    • Mental Health Management


    By Operational Technology Type

    • Flowers
    • Concentrates
    • Hybrids


    By Regional Classification

    • Austria
    • Belgium
    • Bulgaria
    • Croatia
    • Republic of Cyprus
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg
    • Malta
    • Netherlands
    • Poland
    • Portugal
    • Romania
    • Slovakia
    • Slovenia
    • Spain
    • Sweden



    Cannabis production, distribution, including ownership should indeed be restricted to’ medical and experimental uses’ within international treaties. To dissuade usage, acquisition of the substance for individual consumption ought to be a felony, and most nations make this punishable by jail.


    Nonetheless, in recent times, numerous governments have lessened their punishments for marijuana users, and many others have allowed the drug’s distribution, permitting us to see diverse control regimes and their repercussions.


    Neither central government throughout Europe favours the liberalization of marijuana for recreational sales, and all nations impose jail penalties for illicit supply. However, various draught legislation have been offered to national legislatures in recent years, as have other proposals in districts or municipalities that have already been denied at the national scale..


    It’s indeed, nevertheless, rich in proteins and has powerful plant fibres, making it ideal for usage in the textile, industrial, and consumer goods sectors.


    It is a sustainable resource that is used to make plastic polymers, building items, textiles, wood, biofuel, paper, and even automobile components. The first house built with hempcrete; a carbon-neutral construction material composed of hemp.


    Aside from that, THC is claimed to contain psychoactive characteristics that provide the high effect of cannabis. As a result, THC-rich strains may be beneficial to persons suffering from physical discomfort, sleeplessness, or sadness.



    This past decade seems to have been a key differentiator again for legalized marijuana market, with multiple states legalising marijuana usage for both recreational and therapeutic purposes.


    Delivering these items to the general public has necessitated significant scientific advancements. Instead of little treatment, farmers are now producing oils as smoking, pills, edible candies, and other products. It will be intriguing to observe how technology advances impact the manner humans become high as the consumers are entering a new period of marijuana usage.


    Tilray Inc. is a leading developer of the Cannabis Production technology as part of medical requirements for integrations in the European market wherein the focus has been on developing large storage farms classified under differential storage classes of operations.


    Given the sluggishness that has engulfed the state-wide legalisation movements around the World, which propelled Canadian cannabis values up and up and up a few decades previously, Tilray’s diversification strategy may be the key to long-term success.


    And establish one of North America’s most intriguing commercial companies. Having formed a partnership with Aphria, a further Canadian cannabis start-up, to form a new corporation. This resulted in two key alterations to the firm’s destiny.


    Aurora Europe is also a leading implementer of medical and person-based cannabis expert in the market. The entity formed an JV wherein the same two firms furthermore made an agreement which grants Aurora entirely separate rights for using EnWave’s Radiant Energy Vacuum (REV) drying innovation throughout all European Union countries but apart from Portugal, as well as a non-exclusive sub-license using the advanced technologies in Canada, and it invested that quantity in Vancouver-based technology firm EnWave.


    Aurora will also get the opportunity to solely licence REV technologies in Australia and across South America, with the exception of Peru. Several choices are available if Aurora satisfies the REV program’s minimum spend order criteria.



    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in theIndustry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2027
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2027
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2027
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix


      Your Cart
      Your cart is emptyReturn to Shop